Primary Navigation for the CDC Web Site
CDC en Español
Cancer Prevention and Control
divider
E-Mail Icon E-mail this page
Printer Friendly Icon Printer-friendly version
divider
 View by Topic
bullet About Us
bullet Resource Library
bullet Publications Available Online
bullet Print Publication Ordering System
bullet Scientific Articles
bullet Comprehensive Cancer Control Plans Search
bullet Preventive Cancer Screening
bullet Program Contacts
bullet Partners
bullet Data
bullet Newsroom
bullet Site Map

Contact Information Centers for Disease
Control and Prevention
Division of Cancer
Prevention and Control
4770 Buford Hwy, NE
MS K-64
Atlanta, GA 30341-3717

Call: 1 (800) CDC-INFO
TTY: 1 (888) 232-6348
FAX: (770) 488-4760

E-mail: cdcinfo@cdc.gov

Submit a Question Online

Fiscal Year 2007 Scientific Articles

Return to index

This page contains a list of citations for selected publications authored by CDC's Division of Cancer Prevention and Control (DCPC) staff members, during the period of October 1, 2006 to September 30, 2007. The citations are organized alphabetically into cancer topic areas.

  • Breast Cancer
  • Cancer Survivorship
  • Cervical Cancer
  • Colorectal Cancer
  • Health Disparities in Cancer
  • National Breast and Cervical Cancer Early Detection Program
  • National Program of Cancer Registries
  • Ovarian Cancer
  • Prostate Cancer
  • Skin Cancer
  • General and Miscellaneous

  • Breast Cancer

    Abrahamson PE, Gammon MD, Lund MJ, Britton JA, Marshall SW, Flagg EW, Porter PL, Brinton LA, Eley JW, Coates RJ. Recreational physical activity and survival among young women with breast cancer. Cancer 2006;107(8):1777–1785.

    Abrahamson PE, Gammon MD, Lund MJ, Flagg EW, Porter PL, Stevens J, Swanson CA, Brinton LA, Eley JW, Coates RJ. General and abdominal obesity and survival among young women with breast cancer. Cancer Epidemiology, Biomarkers and Prevention 2006;15(10):1871–1877.

    Breen N, Cronin KA, Meissner HI, Taplin SH, Tangka FK, Tiro JA, McNeel TS. Reported drop in mammography: is this cause for concern? Cancer 2007;109(12):2405–2409.

    Coughlin SS, Berkowitz Z, Hawkins NA, Tangka F. Breast and colorectal cancer screening and sources of cancer information among older women in the United States: results from the 2003 Health Information National Trends Survey. Preventing Chronic Disease 2007;4(3):A57.

    Richardson LC, Hall IJ. Diagnostic accuracy of the Gail Model in the Black Women's Health Study. Breast Journal 2007;13(4):329–331.

    Ryerson AB, Miller J, Eheman CR, White MC. Use of mammograms among women aged ≥ 40 years—United States, 2000–2005. MMWR 2007;56(3):49–51.

    Stewart SL, Sabatino SA, Foster SL, Richardson LC. Decline in breast cancer incidence—United States, 1999–2003. MMWR 2007;56(22):549–553.

    Trivers KF, Gammon MD, Abrahamson PE, Lund MJ, Flagg EW, Kaufman JS, Moorman PG, Cai J, Olshan AF, Porter PL, Brinton LA, Eley JW, Coates RJ. Association between reproductive factors and breast cancer survival in younger women. Breast Cancer Research and Treatment 2007;103(1):93–102.

    Trivers KF, Gammon MD, Abrahamson PE, Lund MJ, Flagg EW, Moorman PG, Kaufman JS, Cai J, Porter PL, Brinton LA, Eley JW, Coates RJ. Oral contraceptives and survival in breast cancer patients aged 20 to 54 years. Cancer Epidemiology, Biomarkers and Prevention 2007;16(9):1822–1827.

    Cancer Survivorship

    Sabatino SA, Coates RJ, Uhler RJ, Pollack LA, Alley LG, Zauderer LJ. Provider counseling about health behaviors among cancer survivors in the United States. Journal of Clinical Oncology 2007;25(15):2100–2106.

    Cervical Cancer

    Benard VB, Coughlin SS, Thompson T, Richardson LC. Cervical cancer incidence in the United States by area of residence, 1998–2001. Obstetrics and Gynecology 2007;110(3):681–686.

    Byrd TL, Chavez R, Wilson KM. Barriers and facilitators of cervical cancer screening among Hispanic women. Ethnicity and Disease 2007;17(1):129–134.

    Coughlin SS, King J, Richards TB, Ekwueme DU. Cervical cancer screening among women in metropolitan areas of the United States by individual-level and area-based measures of socioeconomic status, 2000 to 2002. Cancer Epidemiology, Biomarkers and Prevention 2006;15(11):2154–2159.

    Markowitz LE, Dunne EF, Saraiya M, Lawson HW, Chesson H, Unger ER. Quadrivalent human papillomavirus vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recommendations and Reports 2007;56(RR-2):1–24.

    Saraiya M, Ahmed F, Krishnan S, Richards TB, Unger ER, Lawson HW. Cervical cancer incidence in a prevaccine era in the United States, 1998–2002. Obstetrics and Gynecology 2007;109(2):360–370.

    Saraiya M, Irwin KL, Carlin L, Chen X, Jain N, Benard V, Montano DE. Cervical cancer screening and management practices among providers in the National Breast and Cervical Cancer Early Detection Program (NBCCEDP). Cancer 2007;110(5);1024–1032.

    Colorectal Cancer

    Centers for Disease Control and Prevention. Notice to Readers: National Colorectal Cancer Awareness Month—March 2007. MMWR 2007;56(10):227–228.

    Coughlin SS, Berkowitz Z, Hawkins NA, Tangka F. Breast and colorectal cancer screening and sources of cancer information among older women in the United States: results from the 2003 Health Information National Trends Survey. Preventing Chronic Disease 2007;4(3):A57.

    Hughes E, McCracken M, Roberts H, Mokdad A, Valluru B, Goodson R, Dunn E, Elam-Evans L, Giles W, Jiles R. Surveillance for Certain Health Behaviors Among States and Selected Local Areas—Behavioral Risk Factor Surveillance System, United States, 2004. MMWR 2006;55(SS07);1–124.

    Ko CW, Riffle S, Shapiro JA, Saunders MD, Lee SD, Tung BY, Kuver R, Larson AM, Kowdley KV, Kimmey MB. Incidence of minor complications and time lost from normal activities after screening or surveillance colonoscopy. Gastrointestinal Endoscopy 2007;65(4):648–656.

    Levin TR, Zhao W, Conell C, Seeff LC, Manninen DL, Shapiro JA, Schulman J. Complications of colonoscopy in an integrated health care delivery system. Annals of Internal Medicine 2006;145(12):880–886.

    Lieberman D, Nadel M, Smith RA, Atkin W, Duggirala SB, Fletcher R, Glick SN, Johnson CD, Levin TR, Pope JB, Potter MB, Ransohoff D, Rex D, Schoen R, Schroy P, Winawer S. Standardized colonoscopy reporting and data system: Report of the Quality Assurance Task Group of the National Colorectal Cancer Roundtable. Gastrointestinal Endoscopy 2007;65(6):757–766.

    Health Disparities in Cancer

    Clutter GG, Cardinez CJ, Fairley TL. Collecting information on race and ethnicity: A resource for hospital and state central cancer registrars. Journal of Registry Management 2006;33(4):111–118.

    Coughlin SS, King J, Richards TB, Ekwueme DU. Cervical cancer screening among women in metropolitan areas of the United States by individual-level and area-based measures of socioeconomic status, 2000 to 2002. Cancer Epidemiology, Biomarkers and Prevention 2006;15(11):2154–2159.

    Goff BA, Matthews BJ, Wynn M, Muntz HG, Lishner DM, Baldwin LM. Ovarian cancer: patterns of surgical care across the United States. Gynecologic Oncology 2006;103(2):383–390.

    Howe HL, Wu X, Ries LA, Cokkinides V, Ahmed F, Jemal A, Miller B, Williams M, Ward E, Wingo PA, Ramirez A, Edwards BK. Annual report to the nation on the status of cancer, 1975–2003, featuring cancer among U.S. Hispanic/Latino populations. Cancer 2006;107(8):1711–1742.

    Stroud L, Ross LE, Rose SW. Formative evaluation of the prostate cancer screening practices of African-American physicians. Journal of the National Medical Association 2006;98(10):1637–1643.

    National Breast and Cervical Cancer Early Detection Program

    Tangka FK, Dalaker J, Chattopadhyay SK, Gardner JG, Royalty J, Hall IJ, DeGroff A, Blackman DK, Coates RJ. Meeting the mammography screening needs of underserved women: the performance of the National Breast and Cervical Cancer Early Detection Program in 2002–2003 (United States). Cancer Causes and Control 2006;17(9):1145–1154.

    National Program of Cancer Registries (NPCR)

    Benard VB, Coughlin SS, Thompson T, Richardson LC. Cervical cancer incidence in the United States by area of residence, 1998–2001. Obstetrics and Gynecology 2007;110(3):681–686.

    Capron SJ, Seiffert J. Computer Aspects of Data Management: Data Editing. In: Central Cancer Registries: Design, Management and Use, Second Edition. HR Menck, D Deapen, JL Phillips, TC Tucker, eds. Dubuque, Kendall/Hunt Publishing Company, 2007.

    Clutter GG, Cardinez CJ, Fairley TL. Collecting information on race and ethnicity: A resource for hospital and state central cancer registrars. Journal of Registry Management 2006;33(4):111–118.

    Clutter GG, Couillar-Getreuer D, Hoyler SS. Cancer Registrar Certification: The CTR, a Professional Credential. In: Central Cancer Registries: Design, Management and Use, Second Edition. HR Menck, D Deapen, JL Phillips, TC Tucker, eds. Dubuque, Kendall/Hunt Publishing Company, 2007.

    Gerlach KA, Scharber W, Durbin E. Electronic Reporting. In: Central Cancer Registries: Design, Management and Use, Second Edition. HR Menck, D Deapen, JL Phillips, TC Tucker, eds. Dubuque, Kendall/Hunt Publishing Company, 2007.

    Intelkofer R, Michaud F. The National Program of Cancer Registries. In: Central Cancer Registries: Design, Management and Use, Second Edition. HR Menck, D Deapen, JL Phillips, TC Tucker, eds. Dubuque, Kendall/Hunt Publishing Company, 2007.

    Joseph DA, Wingo PA, King JB, Pollack LA, Richardson LC, Wu X, Chen V, Austin HD, Rogers D, Cook J. Use of state cancer surveillance data to estimate the cancer burden in disaster-affected areas—Hurricane Katrina, 2005. Prehospital and Disaster Medicine 2007;22(4):282–290.

    Saraiya M, Ahmed F, Krishnan S, Richards TB, Unger ER, Lawson HW. Cervical cancer incidence in a prevaccine era in the United States, 1998–2002. Obstetrics and Gynecology 2007;109(2):360–370.

    Seiffert J, McKeen K. Death Clearance. In: Central Cancer Registries: Design, Management and Use, Second Edition. HR Menck, D Deapen, JL Phillips, TC Tucker, eds. Dubuque, Kendall/Hunt Publishing Company, 2007.

    Stewart SL, Sabatino SA, Foster SL, Richardson LC. Decline in breast cancer incidence—United States, 1999–2003. MMWR 2007;56(22):549–553.

    Subramanian S, Green J, Tangka F, Weir H, Michaud F, Ekwueme D. Economic assessment of central cancer registry operations. Part I: Methods and conceptual framework. Journal of Registry Management 2007;34(3):75–80.

    Thoburn KK, German RR, Lewis M, Nichols PJ, Ahmed F, Jackson-Thompson J. Case completeness and data accuracy in the Centers for Disease Control and Prevention's National Program of Cancer Registries. Cancer 2007;109(8):1607–1616.

    Van loon S, Mulvihill L. Recruitment and retention of central registry staff. In: Central Cancer Registries: Design, Management and Use, Second Edition. HR Menck, D Deapen, JL Phillips, TC Tucker, eds. Dubuque, Kendall/Hunt Publishing Company, 2007.

    Weir HK, Tucker TC. Registry Certification. In: Central Cancer Registries: Design, Management and Use, Second Edition. HR Menck, D Deapen, JL Phillips, TC Tucker, eds. Dubuque, Kendall/Hunt Publishing Company, 2007.

    Ovarian Cancer

    Darcy KM, Tian C, Reed E. A Gynecologic Oncology Group study of platinum-DNA adducts and excision repair cross-complementation group 1 expression in optimal, stage III epithelial ovarian cancer treated with platinum-taxane chemotherapy. Cancer Research 2007;67(9):4474–4481.

    Goff BA, Matthews BJ, Larson EH, Andrilla CH, Wynn M, Lishner DM, Baldwin LM. Predictors of comprehensive surgical treatment in patients with ovarian cancer. Cancer 2007;109(10):2031–2042.

    Goff BA, Matthews BJ, Wynn M, Muntz HG, Lishner DM, Baldwin LM. Ovarian cancer: patterns of surgical care across the United States. Gynecologic Oncology 2006;103(2):383–390.

    Herrinton LJ, Neslund-Dudas C, Rolnick SJ, Hornbrook MC, Bachman DJ, Darbinian JA, Jackson JM, Coughlin SS. Complications at the end of life in ovarian cancer. Journal of Pain and Symptom Management 2007;34(3):237–243.

    Jackson JM, Rolnick SJ, Coughlin SS, Neslund-Dudas C, Hornbrook MC, Darbinian J, Bachman DJ, Herrinton LJ. Social support among women who died of ovarian cancer. Supportive Care in Cancer 2007;15(5):547–556.

    Rolnick SJ, Jackson J, Nelson WW, Butani A, Herrinton LJ, Hornbrook M, Neslund-Dudas C, Bachman DJ, Coughlin SS. Pain management in the last six months of life among women who died of ovarian cancer. Journal of Pain and Symptom Management 2007;33(1):24–31.

    Ryerson AB, Eheman C, Burton J, McCall N, Blackman D, Subramanian S, Richardson LC. Symptoms, diagnoses, and time to key diagnostic procedures among older U.S. women with ovarian cancer. Obstetrics and Gynecology 2007;109(5):1053–1061.

    Wynn ML, Chang S, Peipins L. Temporal patterns of conditions and symptoms potentially associated with ovarian cancer. Journal of Women's Health 2007;16(7):971–986.

    Prostate Cancer

    Berge V, Thompson T, Blackman D. Use of additional treatment for prostate cancer after radical prostatectomy, radiation therapy, androgen deprivation, or watchful waiting. Scandinavian Journal of Urology and Nephrology 2007;41(3):198–203.

    Hughes E, McCracken M, Roberts H, Mokdad AH, Valluru B, Goodson R, Dunn E, Elam-Evans L, Giles W, Jiles R. Surveillance for certain health behaviors among states and selected local areas—Behavioral Risk Factor Surveillance System, United States, 2004. MMWR Surveillance Summaries 2006;55(7):1–124.

    Lacher DA, Thompson TD, Hughes JP, Saraiya M. Total, free, and percent free prostate-specific antigen levels among U.S. men, 2001–04. (PDF) Advance Data from Vital and Health Statistics no. 379. Hyattsville, MD: National Center for Health Statistics, 2006.

    Marcella S, Delnevo CD, Coughlin SS. A national survey of medical students’ beliefs and knowledge in screening for prostate cancer. Journal of General Internal Medicine 2007;22(1):80–85.

    QuickStats: Percentage of Men Aged ≥ 40 Years* with Prostate-Specific Antigen (PSA) Levels of ≥ 2.5 and ≥ 4.0 ng/mL, by Race/Ethnicity—National Health and Nutrition Examination Survey, United States, 2001–2004. MMWR 2006;55(48);1305.

    Ramsey SD, Zeliadt SB, Hall IJ, Ekwueme DU, Penson DF. On the importance of race, socioeconomic status and comorbidity when evaluating quality of life in men with prostate cancer. Journal of Urology 2007;177(6):1992–1999.

    Ross LE, Richardson LC, Berkowitz Z. The effect of physician-patient discussions on the likelihood of prostate-specific antigen testing. Journal of the National Medical Association 2006;98(11):1823–1829.

    Stroud L, Ross LE, Rose SW. Formative evaluation of the prostate cancer screening practices of African-American physicians. Journal of the National Medical Association 2006;98(10):1637–1643.

    Werny DM, Saraiya M, Gregg EW. Prostate-specific antigen values in diabetic and nondiabetic US men, 2001–2002. American Journal of Epidemiology 2006;164(10):978–983.

    Werny DM, Thompson T, Saraiya M, Freedman D, Kottiri BJ, German RR, Wener M. Obesity is negatively associated with prostate-specific antigen in U.S. men, 2001–2004. Cancer Epidemiology, Biomarkers and Prevention 2007;16(1):70–76.

    Skin Cancer

    Glanz K, Buller DB, Saraiya M. Reducing ultraviolet radiation exposure among outdoor workers: State of the evidence and recommendations. Environmental Health 2007;6(1):22.

    Saraiya M, Balluz L, Wen XJ, Joseph DA. Sunburn Prevalence Among Adults—United States, 1999, 2003, and 2004. MMWR 2007;56(21);524–528.

    General and Miscellaneous

    Chumbler NR, Mkanta WN, Richardson LC, Harris L, Darkins A, Kobb R, Ryan P. Remote patient-provider communication and quality of life: empirical test of a dialogic model of cancer care. Journal of Telemedicine and Telecare 2007;13(1):20–25.

    Coughlin SS. Ethical issues in epidemiology. In: Principles of Health Care Ethics, 2nd Edition. RE Ashcroft, A Dawson, H Draper, J McMillan, eds. Hoboken, NJ, John Wiley & Sons, Inc., 2007.

    Coughlin SS. Ethical issues in epidemiologic research and public health practice. Emerging Themes in Epidemiology 2006;3(1):16.

    Coughlin SS. Hope, ethics, and public health. Journal of Epidemiology and Community Health 2006;60(10):826–827.

    Espey DK, Baum SL, Jung AM, Kozoll RL. The New Mexico Clinical Prevention Initiative: a statewide prevention partnership. Public Health Reports 2007;122(3):292–301.

    Howe HL, Wu X, Ries LA, Cokkinides V, Ahmed F, Jemal A, Miller B, Williams M, Ward E, Wingo PA, Ramirez A, Edwards BK. Annual report to the nation on the status of cancer, 1975–2003, featuring cancer among U.S. Hispanic/Latino populations. Cancer 2006;107(8):1711–1742.

    Hutchinson AB, Farnham PG, Dean HD, Ekwueme DU, Del Rio C, Kamimoto L, Kellerman SE. The economic burden of HIV in the United States in the era of highly active antiretroviral therapy: evidence of continuing racial and ethnic differences. Journal of Acquired Immune Deficiency Syndromes 2006;43(4):451–457.

    Mensah GA, Catravas JD, Engelgau MM, Hooper WC, Madeddu P, Ryan US, She JX, Reed E, Vinicor F, Yacoub MH. Vascular endothelium summary statement VI: Research directions for the 21st century. Vascular Pharmacology 2007;46(5):330–332.

    Ottoson J, Rivera M, Degroff A, Hackley S, Clark C. On the road to the national objectives: A case study of diabetes prevention and control programs. Journal of Public Health Management and Practice 2007;13(3):287–295.

    Reed E, Seffrin J, Giavazzi R, van Hinsbergh V, Madeddu P. Vascular endothelium summary statement III: Cancer prevention and control. Vascular Pharmacology 2007;46(5):321–323.

    Sabatino SA, Coates RJ, Uhler RJ, Pollack LA, Alley LG, Zauderer LJ. Provider counseling about health behaviors among cancer survivors in the United States. Journal of Clinical Oncology 2007;25(15):2100–2106.

    Trogdon JG, Finkelstein EA, Nwaise IA, Tangka FK, Orenstein D. The economic burden of chronic cardiovascular disease for major insurers. Health Promotion Practice 2007;8(3):234–242.

    U.S. Cancer Statistics Working Group. United States Cancer Statistics: 2003 Incidence and Mortality. Atlanta, U.S. Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute, 2006.

    Wang Y, Wiltshire T, Senft J, Reed E, Wang W. Irofulven induces replication-dependent CHK2 activation related to p53 status. Biochemical Pharmacology 2007;73(4):469–480.

    Wilson KM, Satterfield DW. Where are we to be in these times? The place of chronic disease prevention in community health promotion. Preventing Chronic Disease 2007;4(3):A74.

    PDF Icon Please note: Some of these publications are available for download only as *.pdf files. These files require Adobe Acrobat Reader in order to be viewed. Please review the information on downloading and using Acrobat Reader software.

    Page last reviewed: July 2, 2008
    Page last updated: July 2, 2008
    Content source: Division of Cancer Prevention and Control, National Center for Chronic Disease Prevention and Health Promotion
      Home | Policies and Regulations | Disclaimer | e-Government | FOIA | Contact Us
    Safer, Healthier People

    Centers for Disease Control and Prevention
    1600 Clifton Rd, Atlanta, GA 30333, U.S.A.
    800-CDC-INFO (800-232-4636) TTY: (888) 232-6348, 24 Hours/Every Day - cdcinfo@cdc.gov
    USA.govDHHS Department of Health
    and Human Services